Sign up for our newsletter

Most newest results

How Pfizer is targeting Covid with new sustainability bond

How Pfizer is targeting Covid with new sustainability bond

The US drugs giant will use proceeds from its second sustainability bond issue to tackle the pandemic, including in emerging markets. ESG head Chris Gray seeks to dispel scepticism by explaining the deal's rationale, while treasurer Brian McMahon discusses the $1bn bond’s pricing.

Shareholder resolutions surge, but impact in doubt

Shareholder resolutions surge, but impact in doubt

The year to date has seen record-breaking support for shareholder resolutions, with asset managers such as BlackRock and Vanguard stepping up their stewardship. However, a lack of data on the real-world impact means the jury is still out on their efficacy.

Sovereign bound

Sovereign bound

Investors’ exposure to government bonds from countries associated with human rights violations highlights the limitations of shareholder engagement. We take a look at how BlackRock and Vanguard handle this issue.